Medeon Biodesign, Inc. (TPEX:6499)
Taiwan · Delayed Price · Currency is TWD 104.50
-1.50 (-1.42%)
Oct 31, 2025, 2:31 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 9.63 billion as of October 31, 2025. Its market cap has increased by 127.17% in one year.
Market Cap
9.63B
Enterprise Value
9.00B
Revenue
394.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
104.50
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 9.63B, an increase of 66.90%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 9.63B | 163.56% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | 3.64B | -13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |